Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tania Rivera-Hernandez

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|May 21, 2020
Humanized Plasminogen Mouse Model to Study Group A Streptococcus Invasive DiseaseTania Rivera-Hernandez, Mark J Walker
ACS Infectious Diseases|May 15, 2020
Development of an Enzyme-Mediated, Site-Specific Method to Conjugate Toll-Like Receptor 2 Agonists onto Protein Antigens: Toward a Broadly Protective, Four Component, Group A Streptococcal Self-Adjuvanting Lipoprotein-Fusion Combination VaccineZhenghui Xu, Tania Rivera-Hernandez, Peter Michael Moyle
FEBS Letters|June 18, 2016
Streptococcus pyogenes adhesion and colonizationStephan Brouwer, Timothy C Barnett, Tania Rivera-Hernandez, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 24, 2019
Semisynthetic, self-adjuvanting vaccine development: Efficient, site-specific sortase A-mediated conjugation of Toll-like receptor 2 ligand FSL-1 to recombinant protein antigens under native conditions and application to a model group A streptococcal vaccineZhenghui Xu, Tania Rivera-Hernandez, Oishee Chatterjee, et al.
Current Opinion in Immunology|May 13, 2015
Host-pathogen interaction during bacterial vaccinationTimothy C Barnett, Jin Yan Lim, Amelia T Soderholm, et al.
Cellular Microbiology|October 4, 2015
Streptococcal toxins: role in pathogenesis and diseaseTimothy C Barnett, Jason N Cole, Tania Rivera-Hernandez, et al.
NPJ Vaccines|May 9, 2018
Skin infection boosts memory B-cells specific for a cryptic vaccine epitope of group A streptococcus and broadens the immune response to enhance vaccine efficacyManisha Pandey, Victoria Ozberk, Emma L Langshaw, et al.
Frontiers in Immunology|November 2, 2020
Chimeric Virus-Like Particles and Capsomeres Induce Similar CD8<sup>+</sup> T Cell Responses but Differ in Capacity to Induce CD4<sup>+</sup> T Cell Responses and Antibody ResponsesDavid J Pattinson, Simon H Apte, Nani Wibowo, et al.
Discovery Medicine|January 1, 2015
The contribution of non-human primate models to the development of human vaccinesTania Rivera-Hernandez, Diane G Carnathan, Peter M Moyle, et al.
ACS Infectious Diseases|February 3, 2021
Immunogenicity Assessment of Cell Wall Carbohydrates of Group A <i>Streptococcus</i> via Self-Adjuvanted Glyco-lipopeptidesFarjana Khatun, Charles C Dai, Tania Rivera-Hernandez, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Methods in Molecular Biology (Clifton, N.J.)|May 21, 2020
Humanized Plasminogen Mouse Model to Study Group A Streptococcus Invasive DiseaseTania Rivera-Hernandez, Mark J Walker
ACS Infectious Diseases|May 15, 2020
Development of an Enzyme-Mediated, Site-Specific Method to Conjugate Toll-Like Receptor 2 Agonists onto Protein Antigens: Toward a Broadly Protective, Four Component, Group A Streptococcal Self-Adjuvanting Lipoprotein-Fusion Combination VaccineZhenghui Xu, Tania Rivera-Hernandez, Peter Michael Moyle
FEBS Letters|June 18, 2016
Streptococcus pyogenes adhesion and colonizationStephan Brouwer, Timothy C Barnett, Tania Rivera-Hernandez, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 24, 2019
Semisynthetic, self-adjuvanting vaccine development: Efficient, site-specific sortase A-mediated conjugation of Toll-like receptor 2 ligand FSL-1 to recombinant protein antigens under native conditions and application to a model group A streptococcal vaccineZhenghui Xu, Tania Rivera-Hernandez, Oishee Chatterjee, et al.
Current Opinion in Immunology|May 13, 2015
Host-pathogen interaction during bacterial vaccinationTimothy C Barnett, Jin Yan Lim, Amelia T Soderholm, et al.
Cellular Microbiology|October 4, 2015
Streptococcal toxins: role in pathogenesis and diseaseTimothy C Barnett, Jason N Cole, Tania Rivera-Hernandez, et al.
NPJ Vaccines|May 9, 2018
Skin infection boosts memory B-cells specific for a cryptic vaccine epitope of group A streptococcus and broadens the immune response to enhance vaccine efficacyManisha Pandey, Victoria Ozberk, Emma L Langshaw, et al.
Frontiers in Immunology|November 2, 2020
Chimeric Virus-Like Particles and Capsomeres Induce Similar CD8<sup>+</sup> T Cell Responses but Differ in Capacity to Induce CD4<sup>+</sup> T Cell Responses and Antibody ResponsesDavid J Pattinson, Simon H Apte, Nani Wibowo, et al.
Discovery Medicine|January 1, 2015
The contribution of non-human primate models to the development of human vaccinesTania Rivera-Hernandez, Diane G Carnathan, Peter M Moyle, et al.
ACS Infectious Diseases|February 3, 2021
Immunogenicity Assessment of Cell Wall Carbohydrates of Group A <i>Streptococcus</i> via Self-Adjuvanted Glyco-lipopeptidesFarjana Khatun, Charles C Dai, Tania Rivera-Hernandez, et al.
Pageof 4